Scheifele D W, Ginter G L, Olsen E, Fussell S, Pendray M
Department of Paediatrics, University of British Columbia, Vancouver, Canada.
J Antimicrob Chemother. 1987 Sep;20(3):421-9. doi: 10.1093/jac/20.3.421.
Treatment of neonatal necrotizing enterocolitis (NEC) regularly includes broad-spectrum antibiotics but there has been no comparative study of alternative regimens. We have studied 90 infants with definite NEC; 46 cases in 1982-3 were treated with ampicillin and gentamicin, while 44 cases in 1984-5 received cefotaxime and vancomycin. Groups were well matched and managed uniformly. Infants greater than or equal to 2200 g birthweight did well with either regimen. Smaller infants given cefotaxime and vancomycin had a lower risk of culture-positive peritonitis (P = 0.01), and as a result, were less likely to die (P = 0.048) or develop thrombocytopenia (P = 0.004). The better outcome might be explained by the greater suppression by cefotaxime and vancomycin of the gut flora of treated patients (P less than 0.001). Both regimens were well-tolerated. Our data suggest that carefully chosen antibiotic regimens can improve the outcome of NEC.
新生儿坏死性小肠结肠炎(NEC)的治疗通常包括使用广谱抗生素,但尚未有关于替代方案的比较研究。我们研究了90例确诊为NEC的婴儿;1982 - 1983年的46例患者接受氨苄西林和庆大霉素治疗,而1984 - 1985年的44例患者接受头孢噻肟和万古霉素治疗。两组匹配良好且管理一致。出生体重≥2200g的婴儿采用任何一种方案治疗效果都较好。接受头孢噻肟和万古霉素治疗的较小婴儿发生培养阳性腹膜炎的风险较低(P = 0.01),因此死亡(P = 0.048)或发生血小板减少症(P = 0.004)的可能性较小。更好的治疗结果可能是由于头孢噻肟和万古霉素对接受治疗患者肠道菌群的抑制作用更强(P<0.001)。两种方案耐受性均良好。我们的数据表明,精心选择的抗生素方案可改善NEC的治疗结果。